Leukemia Treatment Derived From Cord Blood Gains FDA Approval for Clinical Trials
A CAR-T cell therapy for acute lymphoblastic leukemia[1] has recently been approved by the FDA for use in clinical trials in the United States. The therapy is based on cells derived from allogeneic (donor) umbilical cord blood; it is the very first such treatment to...
Toddler’s Rare Leukemia Treated by Sister’s Cord Blood
After two planned transplants from unrelated donors fell through at the very last minute, Australian three-year-old Tommy Bacon is now in remission from a rare, dangerous form of leukemia following a transplant of the stem cells from his baby sister’s cord blood.[1]...
Combination Therapy Using Umbilical Cord Stem Cells Could Be Key to Treating Spinal Cord Injuries
A new study on the effectiveness of treatment for spinal cord injuries indicates that a combination therapy, including epidural electrical stimulation (EES) as well as neural stem cells and umbilical cord stem cells, could offer better results than any one treatment...
World Cord Blood Day 2024
Today marks World Cord Blood Day – a day dedicated to highlighting the medical breakthrough that began 36 years ago, in 1988, with a single transplant. That cord blood transplant opened the door to a new era in medicine. Since then, stem cells from cord blood...
Stem Cells Restore Vision in World First
A recent study published in the Lancet journal has shown that stem cells have been used to bring about significant improvements in vision in what’s being heralded as a world first. The stem cell treatment focused on the repair of the cornea which becomes damaged in...
